Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

69.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 121.20
  • 52 Week Low: 35.30
  • Currency: UK Pounds
  • Shares Issued: 540.00m
  • Volume: 2,886,505
  • Market Cap: 372.60m
  • RiskGrade: 119
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 189.57 43.33 5.48p 12.6 0.4 +28% 1.84p 0.0%
31-Dec-24 211.70 50.69 6.66p 10.4 0.5 +22% 1.98p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
31-Dec-2023 190 190 190 194 206 202
31-Dec-2024 212 212 212 217 n/a n/a
 
Earnings
31-Dec-2023 5.48p 5.48p 547.98p 6.03p 6.84p 6.88p
31-Dec-2024 6.66p 6.66p 665.72p 7.01p n/a n/a
 
Dividend
31-Dec-2023 1.84p 1.84p 183.55p 1.83p 1.82p 1.80p
31-Dec-2024 1.98p 1.98p 198.16p 1.97p n/a n/a
 
Recommendations
Strong Buy 4 4 4 4 5 4
Buy 1 1 1 1 0 0
Neutral 2 2 1 1 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 7 7 6 6 5 4
 
Average Rec 8.21 8.21 8.75 8.75 10.00 10.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 69.00p
Change Today 1.00p
% Change 1.47 %
52 Week High 121.20
52 Week Low 35.30
Volume 2,886,505
Shares Issued 540.00m
Market Cap 372.60m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.27% above the market average20.27% above the market average20.27% above the market average20.27% above the market average20.27% above the market average
49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average49.15% above the sector average
Price Trend
13.47% below the market average13.47% below the market average13.47% below the market average13.47% below the market average13.47% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income
40.83% below the market average40.83% below the market average40.83% below the market average40.83% below the market average40.83% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Growth
88.81% below the market average88.81% below the market average88.81% below the market average88.81% below the market average88.81% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 31-Mar-2023

Time Volume / Share Price
17:02 3,130 @ 68.57p
17:02 1,009 @ 68.57p
17:02 1,147 @ 68.57p
17:01 3,130 @ 68.58p
17:01 1,009 @ 68.58p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page